To explore the underlying mechanism through which NFKBIZ regulates HCC cells, we focused on three pathways known to be abnormally activated during HCC development: PI3K/AKT, Wnt/β-catenin, and NFκB. This evidence concerns the gene AKT1 and hepatocellular carcinoma.